BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38101785)

  • 1. [Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome].
    Hong LR; Chen YJ; Jiang QL; Jia RL; Li C; Feng LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1033-1038. PubMed ID: 38101785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
    Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
    Huang K; Mo Q; Liao C; Feng S; Liu G; Jiang D; Lei P
    Clin Exp Med; 2024 May; 24(1):107. PubMed ID: 38776019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influencing factors of thrombosis besides antiphospholipid antibodies in patients with antiphospholipid syndrome].
    Fan YY; Chen C; Liu HJ; Cai WX; Hou YK; Li C
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(43):3588-3593. PubMed ID: 34808753
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of novel thrombotic markers for predicting occurrence of the malignant cerebral artery infarction: a prospective clinical study.
    Zhao X; Yang S; Lei R; Liu Y; Duan Q; Li J; Sun L
    Front Neurol; 2023; 14():1238742. PubMed ID: 38099069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
    Wang L; Zhong J; Xiao D; Huang W; Zheng Z; Jiang Y
    Ann Transl Med; 2022 Dec; 10(23):1273. PubMed ID: 36618792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction.
    Zhao X; Yang S; Lei R; Duan Q; Li J; Meng J; Sun L
    Front Neurol; 2022; 13():942887. PubMed ID: 36761916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.
    Ren W; Zhang J; Chen Y; Wen M; Su Y; Zhao Y; Lu S; Wu J
    Clin Appl Thromb Hemost; 2020; 26():1076029620982666. PubMed ID: 33356499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of thrombin-antithrombin III complex and tissue plasminogen activator-inhibitor complex biomarkers in assessing the severity of early-stage acute pancreatitis.
    Liao C; Liu G; Li L; Wang J; Ouyang L; Lei P; Fan S
    J Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38822643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
    Ząbczyk M; Celińska-Löwenhoff M; Plens K; Iwaniec T; Musiał J; Undas A
    J Thromb Haemost; 2019 Oct; 17(10):1746-1755. PubMed ID: 31220407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of Coagulation and Fibrinolysis Biomarker in Lung Cancer Patients with Thromboembolism].
    Fu Y; Liu Y; Jin Y; Jiang H
    Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):583-587. PubMed ID: 30172264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
    Nascimento IS; Radin M; Gândara APR; Sciascia S; de Andrade DCO
    Lupus; 2020 Jun; 29(7):676-685. PubMed ID: 32279584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of thrombus molecular markers thrombomodulin, thrombin-antithrombin complex, plasmin-α2-plasmin inhibitor complex, and tissue plasminogen activator-inhibitor complex by a chemiluminescence analyzer.
    Lirong T; Minmin X; Manqiu Y; Yanping L
    Hippokratia; 2022; 26(2):78-82. PubMed ID: 37188051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
    Yang Y; Hu Y; Wu M; Xiang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):469-478. PubMed ID: 35545342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of coagulation markers in patients with colorectal caner: A prospective study.
    Chen W; Li Y; Wang W; Xue Y; Qian J; Liu W; Hu X
    Health Sci Rep; 2024 Feb; 7(2):e1553. PubMed ID: 38304067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.